NextGen Healthcare (NextGen Healthcare) Risk Assessment

View and export this data going back to 1982. Start your Free Trial

What is NextGen Healthcare Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of NextGen Healthcare is: No Data: Cannot be evaluated.

Competitive Comparison of NextGen Healthcare's Risk Assessment

For the Health Information Services subindustry, NextGen Healthcare's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NextGen Healthcare's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NextGen Healthcare's Risk Assessment distribution charts can be found below:

* The bar in red indicates where NextGen Healthcare's Risk Assessment falls into.

NextGen Healthcare (NAS:NXGN) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

NextGen Healthcare Risk Assessment Related Terms

Thank you for viewing the detailed overview of NextGen Healthcare's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

NextGen Healthcare (NextGen Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NextGen Healthcare Inc (NAS:NXGN) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

3525 Piedmont Road, NE Building 6, Suite 700, Atlanta, GA, USA, 30305

Website

https://www.nextgen.com

NextGen Healthcare Inc is a United States-based company that provides healthcare solutions. The company offers technology and services platform supports for ambulatory and specialty practices of all sizes. It provides software, services, and analytics solutions to medical and dental group practices.

Executives

Three Prong Investments, Llc	10 percent owner	1695 VIKING RD, LAGUNA BEACH CA 92651
David A Metcalfe	officer: Chief Technology Officer	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Mitchell Waters	officer: EVP, Commercial Growth	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Craig A. Barbarosh	director	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
David Ahmadzai	officer: Chief Accounting Officer	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Donna Cullen Greene	officer: EVP, Human Resources	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Srinivas S Velamoor	officer: EVP, Business Development	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
David William Sides	officer: President and CEO	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Arnold James Robert Jr.	officer: Chief Financial Officer	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Darnell Dent	director	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Pamela Puryear	director	253 DOLPHIN COVE QUAY, STAMFORD CT 06902
Geraldine Mcginty	director	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Lonnie Allen Plunk	officer: EVP, Operations	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
John R Frantz	officer: CEO and President	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Lance Rosenzweig	director	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305